Document is current
Any future updates will be listed below
-
Authors
Abdayem, Pamela https://orcid.org/0000-0002-4477-3633
Parisi, Claudia https://orcid.org/0000-0002-6259-8234
Planchard, David https://orcid.org/0000-0002-1565-8310
-
Funding
Funding for this research was provided by:
Université Paris-Saclay
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 6 December 2025
First Online: 31 January 2026
Declarations
:
: P. Abdayem received speaker honoraria from AstraZeneca, Netcancer, MSD, and travel grants from Pierre Fabre, Eli Lilly, Pfizer and Roche, outside the submitted work. C. Parisi declares no conflicts of interest that might be relevant to the contents of this manuscript. D. Planchard received honoraria from AstraZeneca, Abbvie, Bristol Myers Squibb, Daiichi-Sankyo, Merck, Novartis, Janssen, Pfizer, Roche, and Sanofi-Aventis and institutional financial fees from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Pfizer, Roche, Medimmun, Sanofi-Aventis, Taiho Pharma, Novocure, Daiichi Sankyo, Abbvie, Janssen, Pierre-fabre, Takeda, ArriVent, Mirati, Seagen, outside the submitted work.
: Not applicable.
: Not applicable.
: All authors provided consent for publication of this manuscript.
: No datasets were generated or analysed during the current study.
: No code was generated during the current study.
